Evidence map›Paper›PMID 38695101›Full record

ArticleJournal of the International AIDS Society2024

Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.

Elzette Rousseau, Kathleen J Sikkema, Robin F Julies, Katelyn Mazer, Gabrielle O'Malley, Renee Heffron, Jennifer F Morton, Rachel Johnson, Connie Celum, Jared M Baeten and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Elzette RousseauDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-6487-6736
Kathleen J SikkemaDepartment of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York City, New York, USA.
Robin F JuliesDepartment of Psychology, University of the Western Cape, Cape Town, South Africa.
Katelyn MazerDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California, USA.ORCID 0000-0003-0993-1189
Gabrielle O'MalleyDepartment of Global Health, Medicine and Epidemiology, University of Washington, Seattle, Washington, USA.
Renee HeffronDepartment of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0001-6039-0352
Jennifer F MortonDepartment of Global Health, Medicine and Epidemiology, University of Washington, Seattle, Washington, USA.
Rachel JohnsonDepartment of Global Health, Medicine and Epidemiology, University of Washington, Seattle, Washington, USA.
Connie CelumDepartment of Global Health, Medicine and Epidemiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-8813-3419
Jared M BaetenDepartment of Global Health, Medicine and Epidemiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-8242-8438
Linda-Gail BekkerDesmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0755-4386
University of Washington · USDesmond Tutu HIV Foundation · ZACity University of New York · USUniversity of Alabama at Birmingham · USUniversity of California, Los Angeles · USUniversity of the Western Cape · ZA

Funding

USAID AID-OAA-A15-00034
6 · The paper itself

Abstract

introductionAdolescent girls and young women (AGYW), a priority population for HIV prevention in Africa, show high interest but difficulty in sustained effective use of pre-exposure prophylaxis (PrEP). With ongoing PrEP scale-up focused on increasing access, it is important to understand what influences AGYW's choice of PrEP delivery platforms.

methodsThe POWER implementation study in Cape Town provided PrEP between 2017 and 2020 to AGYW (16-25 years) from four differentiated delivery platforms: mobile clinic, government facility, courier delivery or community-based youth club. Healthcare providers at government and mobile clinics provided PrEP (initiation and refills) as part of comprehensive, integrated sexual and reproductive health services. Courier and youth club platforms provided light-touch PrEP refill services incorporating rapid HIV self-testing. We conducted in-depth interviews with a purposive sample of AGYW who had ≥3 months of PrEP-use and accessed ≥2 PrEP delivery platforms. The thematic analysis explored AGYW's preferences, decision-making and habits related to PrEP access to inform market segmentation.

resultsWe interviewed 26 AGYW (median age 20) PrEP-users between November 2020 and March 2021. AGYW PrEP-users reported accessing different services with, 24 accessing mobile clinics, 17 courier delivery, 9 government health facilities and 6 youth clubs for their PrEP refills. Qualitative findings highlighted four potential behavioural profiles. The "Social PrEP-user" preferred PrEP delivery in peer spaces, such as youth clubs or adolescent-friendly mobile clinics, seeking affirmation and social support for continued PrEP use. The "Convenient PrEP-user" favoured PrEP delivery at easily accessible locations, providing quick (courier) or integrated contraception-PrEP refill visits (mobile and government clinic). The "Independent PrEP-user" preferred PrEP delivery that offered control over delivery times that fit into their schedule, such as the courier service. The "Discreet PrEP-user" highly valued privacy regarding their PrEP use (courier delivery) and avoided delivery options where unintentional disclosure was evident (youth club). Comfort with HIV self-testing had minimal influence on PrEP delivery choice.

conclusionsMarket segmentation of AGYW characterizes different types of PrEP-users and has the potential to enhance tailored messaging and campaigns to reach specific segments, with the aim of improving sustained PrEP use and HIV prevention benefits.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultFemaleHumansInterviews as TopicPatient Acceptance of Health CareSouth AfricaYoung AdultAnti-HIV Agentsadolescent girls and young womencourierHIV self‐testingmobile clinicpre‐exposure prophylaxisyouth club

Identifiers

PMID38695101
PMCPMC11063778
OpenAlexW4396585830

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.